文献速递腹部CTMR

肌少性肥胖的影像学量化及其在慢性肝病严重程度中的作用

Radiological Quantification of Sarcopenic Obesity and its Role in Chronic Liver Disease Severity.
PubMed 文献 · Acad Radiol · 2023-04-01

本研究回顾性纳入慢性乙型肝炎、肝硬化和肝细胞癌患者,通过CT和MRI测量骨骼肌指数和内脏脂肪面积来定义肌少性肥胖,并评估其与Child-Pugh和MELD评分的关系。结果显示肝硬化和肝癌患者的肌少症及肌少性肥胖发生率高于慢性乙型肝炎患者,肌少症患者MELD评分更高,肝癌合并肌少性肥胖者MELD评分高于其他体成分分类。

要点

  • CT/MRI可量化骨骼肌指数和内脏脂肪面积,用于定义肌少性肥胖。
  • 肝硬化和肝癌患者肌少症及肌少性肥胖发生率高于慢性乙肝患者。
  • 肌少症与更高MELD评分相关,肝癌合并肌少性肥胖者MELD评分更高。

诊断标准与关键数值

  • 肝硬化患者肌少症和肌少性肥胖发生率高于慢性乙型肝炎患者(p<0.033和p<0.004)。
  • 肝细胞癌患者肌少症和肌少性肥胖发生率高于慢性乙型肝炎患者(p<0.001和p<0.001)。
  • 慢性乙型肝炎、肝硬化和肝细胞癌组中肌少症患者MELD评分高于非肌少症患者(p<0.035、p<0.023和p<0.024)。
  • 肝细胞癌合并肌少性肥胖患者MELD评分高于其他体成分分类患者(p<0.006)。
  • 肝硬化合并肌少性肥胖患者MELD评分高于非肌少性肥胖患者(p<0.049)。

临床应用与阅片要点

  • 在慢性肝病患者的CT或MRI阅片时,可关注骨骼肌指数和内脏脂肪面积,辅助识别肌少性肥胖。
  • 肌少症与MELD评分升高相关,提示可将体成分评估纳入肝病严重程度评价。

局限性

  • 回顾性研究设计。
  • 单中心研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To define sarcopenic obesity (SaO) among chronic liver disease (CLD) patients via CT and MRI, and assess its impact on liver disease severity.

MATERIALS AND METHODS: CLD patients referred from the Gastroenterology and Hepatology Department diagnosed as chronic hepatitis B (N:101), cirrhosis (N:110), and hepatocellular carcinoma (N:169) with available information on body height, weight, Child-Pugh and MELD scores within 2 weeks of CT or MRI scanning were included in the study. Cross-sectional examinations were retrospectively evaluated for skeletal muscle index (SMI) and visceral adipose tissue area (VATA). The disease severity was assessed by Child-Pugh and MELD scoring.

RESULTS: The rate of sarcopenia and SaO in the cirrhotic patients was higher than that in the chronic hepatitis B patients (p <0.033 and p < 0.004, respectively). The rate of sarcopenia and SaO in HCC patients was higher than that in the chronic hepatitis B patients (p <0.001 and p <0.001, respectively). Sarcopenic patients in Chronic hepatitis B, cirrhotic, and HCC groups had higher MELD scores than nonsarcopenic patients (p <0.035, p <0.023, and p <0.024, respectively). Despite finding a similar increase in Child-Pugh scores in cirrhotic and HCC sarcopenic patients, results were statistically insignificant (p <0.597 and p <0.688). HCC patients with SaO had higher MELD scores than patients with other body composition catagories (p <0.006). Cirrhotic patients with SaO had higher MELD scores than nonsarcopenic obese patients (p <0.049). Chronic hepatitis B patients with obesity had low MELD scores (p <0.035). Cirrhotic and HCC patients with obesity had higher MELD scores (p <0.01 and p <0.024, respectively). Cirrhotic and HCC patients with obesity had higher Child-Pugh scores than nonobese patients but only HCC patients showed statistically significance (p <0.480 and p <0.001).

CONCLUSION: Radiologic evaluation of SaO and harmonizing body composition with MELD scoring is critical in CLD management.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Cimsit, Kursun, Demircioglu, et al. Radiological Quantification of Sarcopenic Obesity and its Role in Chronic Liver Disease Severity. Acad Radiol. 2023. PMID: 37012127. doi:10.1016/j.acra.2023.03.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。